Clinical Trials Directory

Trials / Completed

CompletedNCT03156699

The Incidence, Effect and Persistence of Fragmented-QRS, in Patients Presenting With ST-Elevation Myocardial Infarction

Status
Completed
Phase
Study type
Observational
Enrollment
64 (actual)
Sponsor
The Royal Wolverhampton Hospitals NHS Trust · Other Government
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This study will assess the incidence, effect and persistence of F-QRS (Fragmented-QRS) in STEMI (ST-elevation Myocardial Infarction) patients post-PCI (percutaneous coronary intervention). The aim is to add to the existing research field surrounding F-QRS. It is hypothesised that patients with F-QRS present on the surface ECG, following PCI, will have incurred a higher degree of damage. As a result, it is hypothesised that these patients will have reduced LV (left-ventricular) systolic function, increased incidence of regional wall motion abnormalities (RWMAs), and increased troponin levels on admission. This study will additionally look for correlations between F-QRS and culprit vessels. To our knowledge there is minimal research regarding this.

Detailed description

This is a Physiological - Retrospective data collection from STEMI patients. Data from 100 STEMI patients treated with primary PCI will be extracted. Data will be collected from presentation / initial admission, 6-week post-MI (Myocardial Infarction) clinic and 6 month post-MI clinic from the hospital system at New Cross Hospital. Data from admission includes; 12-lead ECG, echo reports and blood test results. Additionally, the 12-lead ECGs undertaken at 6-week and 6-months will be assessed for the presence of F-QRS.

Conditions

Timeline

Start date
2017-09-01
Primary completion
2018-05-01
Completion
2018-05-30
First posted
2017-05-17
Last updated
2019-06-18

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT03156699. Inclusion in this directory is not an endorsement.